EUVIMEDEUVIMED entdecken
Crossref

In Vivo Self‐Assembly of PROTACs by Bioorthogonal Chemistry for Precision Cancer Therapy

Shaowen Xie iD, Jingjie Zhu, Yihan Peng, Fangyi Zhan, Feiyan Zhan, Chen He, Dazhi Feng, Jia Xie, Jingyu Liu, Huajian Zhu, Hong Yao iD, Jinyi Xu iD und 2 weitere

Angewandte Chemie International Edition · 10.03.2025 · 64 (11)

DOI: 10.1002/anie.202421713 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 07.01.2025. Verfasst von Shaowen Xie und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, 639 Longmian Avenue, Nanjing, Jiangsu, 211198, China. Hauptthemen laut MEDLINE: Neoplasms, Antineoplastic Agents, Precision Medicine. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 78 Literaturangaben. Gefördert von: National Natural Science Foundation of China, "Double First Class" University project of China Pharmaceutical University, the Postgraduate Research & Practice Innovation Program of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Proteolysis targeting chimeras (PROTACs) hold immense promise for targeted protein degradation; however, challenges such as off‐target effects, poor drug‐likeness properties, and the “hook effect” remain. This study introduces Nano‐Click‐formed PROTACs (Nano‐CLIPTACs) for precise tumor protein degradation in vivo. Traditional PROTACs with high molecular weight were first divided into two smaller druglike precursors capable of self‐assembling to form functional PROTACs through a bioorthogonal reaction. Then, optimal CLIPTACs precursors ( W4 and Z2 ) were encapsulated individually into cyclic RGDfC‐peptide‐modified liposomes to prepare Nano‐CLIPTACs, enabling tumor‐targeted delivery and subsequent in situ self‐assembly to form PROTACs WZ42 within tumor cells. The degradation abilities of Nano‐CLIPTACs in vitro and in vivo were further verified using a key oncology target, anaplastic lymphoma kinase (ALK), validating the safety, efficacy and “anti‐hook effect” of this strategy. Overall, Nano‐CLIPTACs represent a critical step towards the clinical translation of PROTACs technology for precise targeted anti‐cancer therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsAntineoplastic AgentsPrecision MedicineHumansProteolysisAnimalsClick ChemistryMiceCell Line, TumorLiposomesProteolysis Targeting Chimera

Stichwörter der Autor:innen

PROTACsbioorthogonal chemistryliposomesnano-cliptacsprotein degradation

Substanzen

Antineoplastic AgentsLiposomesProteolysis Targeting Chimera

Autor:innen und Institutionen

  • Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, 639 Longmian Avenue, Nanjing, Jiangsu, 211198, China.
  • Center of Advanced Pharmaceuticals and Biomaterials, School of Pharmacy, China Pharmaceutical University, 639 Longmian Avenue, Nanjing, Jiangsu, 211198, China.

ORCID-Profile: Shaowen Xie, Hong Yao, Jinyi Xu, Shengtao Xu

Förderung

  • National Natural Science Foundation of China
  • "Double First Class" University project of China Pharmaceutical University
  • the Postgraduate Research & Practice Innovation Program of Jiangsu Province

Zitieren

APA

Xie, S., Zhu, J., Peng, Y., Zhan, F., Zhan, F., He, C., Feng, D., Xie, J., Liu, J., Zhu, H., Yao, H., Xu, J., Su, Z., & Xu, S. (2025). In Vivo Self‐Assembly of PROTACs by Bioorthogonal Chemistry for Precision Cancer Therapy. Angewandte Chemie International Edition, 64(11). https://doi.org/10.1002/anie.202421713

Vancouver

Xie S, Zhu J, Peng Y, Zhan F, Zhan F, He C, et al. In Vivo Self‐Assembly of PROTACs by Bioorthogonal Chemistry for Precision Cancer Therapy. Angewandte Chemie International Edition. 2025;64(11). doi:10.1002/anie.202421713

BibTeX
@article{Xie2025,
  author = {Xie, Shaowen and Zhu, Jingjie and Peng, Yihan and Zhan, Fangyi and Zhan, Feiyan and He, Chen and Feng, Dazhi and Xie, Jia and Liu, Jingyu and Zhu, Huajian and Yao, Hong and Xu, Jinyi and Su, Zhigui and Xu, Shengtao},
  title = {In Vivo Self‐Assembly of PROTACs by Bioorthogonal Chemistry for Precision Cancer Therapy},
  journal = {Angewandte Chemie International Edition},
  year = {2025},
  volume = {64},
  number = {11},
  doi = {10.1002/anie.202421713}
}
Kostenlos starten →